What medications are safe for breastfeeding women with anxiety or depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Anxiety and Depression in Breastfeeding Women

Sertraline and paroxetine are the safest antidepressant medications for breastfeeding women with anxiety or depression, as they transfer in lower concentrations to breast milk and produce undetectable infant plasma levels. 1

First-Line Medication Options

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Sertraline (Zoloft):

    • Preferred first-line option with minimal transfer to breast milk 1, 2
    • Begin with low doses and slowly increase with careful monitoring of the infant 2
    • Target the lowest effective dose to minimize infant exposure 2
  • Paroxetine:

    • Also transfers in low concentrations to breast milk 1
    • Suitable first-line agent for breastfeeding mothers 3
    • Produces undetectable infant plasma levels 4

Timing Considerations

  • When possible, take medication immediately after breastfeeding to maximize clearance time before the next feeding 2
  • Consider avoiding breastfeeding at peak medication concentration times to further reduce infant exposure 2

Second-Line Options

  • Other SSRIs:

    • Citalopram and fluoxetine produce higher infant plasma levels and have reported cases of suspected adverse effects 3
    • If mother was treated with these during pregnancy, continuing during breastfeeding may be reasonable with careful monitoring 3
  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors):

    • Venlafaxine produces higher infant plasma concentrations 3
    • Should be used with caution in breastfeeding women 3

Monitoring and Precautions

Infant Monitoring

  • Watch for potential adverse effects in the infant:
    • Irritability
    • Poor feeding
    • Uneasy sleep 2
    • These effects are more concerning in premature infants or those with low birth weight 2

Special Considerations

  • Extra caution needed with infants less than 6 weeks of age due to immature hepatic and renal function
  • Older infants (>6 months) have more mature metabolism and lower risk for adverse effects 5

Non-Pharmacological Approaches

For mild anxiety or depression, consider non-pharmacological approaches first:

  • Exercise therapy
  • Yoga, tai chi, and mindfulness-based stress reduction
  • Massage therapy and acupuncture 5

Clinical Decision-Making Algorithm

  1. Assess severity of anxiety/depression

    • For mild symptoms: Start with non-pharmacological approaches
    • For moderate to severe symptoms: Consider medication
  2. If medication is needed:

    • First choice: Sertraline or paroxetine
    • Start with low dose and titrate slowly
    • Monitor infant for adverse effects
  3. If first-line medications are ineffective:

    • Consider other SSRIs with careful monitoring
    • Individual risk-benefit assessment should be performed 3

Important Considerations

  • The benefits of treating maternal depression often outweigh the minimal risks of medication exposure through breast milk 5
  • Untreated depression can negatively impact infant emotional development 6
  • Depression during pregnancy is associated with premature birth and decreased initiation of breastfeeding 1
  • Most newer antidepressants produce very low or undetectable plasma concentrations in nursing infants 3

Common Pitfalls to Avoid

  • Stopping medication abruptly: This can lead to withdrawal symptoms and worsening depression
  • Underdosing due to fear: Using inadequate doses may fail to treat the condition effectively
  • Avoiding treatment altogether: Untreated depression poses risks to both mother and infant
  • Discontinuing breastfeeding unnecessarily: When antidepressant treatment is indicated, mothers should generally not be advised to discontinue breastfeeding 3

Remember that adequate treatment of maternal mental health conditions is crucial for both mother and infant wellbeing, and the evidence suggests that sertraline and paroxetine can be safely used during breastfeeding with appropriate monitoring.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressant Use During Breastfeeding.

Current women's health reviews, 2011

Guideline

Management of Back Pain in Breastfeeding Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.